xolremdi - mavorixafor capsule, gelatin coated
(Mavorixafor)X4 Pharmaceuticals, Inc.
Usage: Xolremdi is indicated for patients 12 years and older with WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis) to increase circulating mature neutrophils and lymphocytes.